Atlas Trials

Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion

Clinical trial NCT02054078 · UNKNOWN

Trial details

NCT number
NCT02054078
Sponsor
Tang-Du Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Pleural Effusion
Start date
2012-01-01
Primary completion
2014-03-01
Enrollment
183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.